ES2074965A1 - Virus mutante recombinante de rinotraqueitis infecciosa bovina y vacunas que lo contienen. - Google Patents

Virus mutante recombinante de rinotraqueitis infecciosa bovina y vacunas que lo contienen.

Info

Publication number
ES2074965A1
ES2074965A1 ES09400172A ES9400172A ES2074965A1 ES 2074965 A1 ES2074965 A1 ES 2074965A1 ES 09400172 A ES09400172 A ES 09400172A ES 9400172 A ES9400172 A ES 9400172A ES 2074965 A1 ES2074965 A1 ES 2074965A1
Authority
ES
Spain
Prior art keywords
same
production
methods
gll
infectious bovine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES09400172A
Other languages
English (en)
Other versions
ES2074965B1 (es
Inventor
Xavier Rebordosa
Jaume Pinol
Josep Antoni Perez-Pons
Jorge Lloberas
Enrique Querol
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratorios Hipra SA
Original Assignee
Laboratorios Hipra SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Hipra SA filed Critical Laboratorios Hipra SA
Priority to ES09400172A priority Critical patent/ES2074965B1/es
Priority to CA002141392A priority patent/CA2141392A1/en
Priority to EP95870007A priority patent/EP0668356A3/en
Publication of ES2074965A1 publication Critical patent/ES2074965A1/es
Application granted granted Critical
Publication of ES2074965B1 publication Critical patent/ES2074965B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

VIRUS MUTANTE DE RINOTRAQUEITIS INFECCIOSA BOVINA Y VACUNAS QUE LO CONTIENEN. EL VIRUS OBTENIDO, CARACTERIZADO COMO BHV1 FM G11, ES EL RESULTADO DE UNA DELECCION, DE UNA INSERCION, O DE UNA SUSTITUCION (DELECION E INSERCION) EN EL GEN G11 DEL HEPESVIRUS BOVINO 1 (BHV1), QUE NO PRODUCEN NINGUN POLIEPTIDO ANTIGENICO DE LA GLICOPROTEINA G11. EL VIRUS BHV1 FM G11 SE UTILIZA PARA LA PREPARACION DE VACUNAS CONTRA LA RINOTRAQUEITIS INFECCIOSA BOVINA, Y DE KITS DE DIAGNOSTICO PARA DISTINGUIR SEROLOGICAMENTE ENTRE ANIMALES VACUNADOS E INFECTADOS POR VIRUS DE CAMPO.
ES09400172A 1994-01-31 1994-01-31 Virus mutante recombinante de rinotraqueitis infecciosa bovina y vacunas que lo contienen. Expired - Fee Related ES2074965B1 (es)

Priority Applications (3)

Application Number Priority Date Filing Date Title
ES09400172A ES2074965B1 (es) 1994-01-31 1994-01-31 Virus mutante recombinante de rinotraqueitis infecciosa bovina y vacunas que lo contienen.
CA002141392A CA2141392A1 (en) 1994-01-31 1995-01-30 Recombinant infectious bovine rhinotracheitis virus mutant, methods for the production of same, and vaccines containing the same
EP95870007A EP0668356A3 (en) 1994-01-31 1995-01-31 Recombinant infectious bovine rhinotracheitis virus mutant, methods for the production of same, and vaccines containing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES09400172A ES2074965B1 (es) 1994-01-31 1994-01-31 Virus mutante recombinante de rinotraqueitis infecciosa bovina y vacunas que lo contienen.

Publications (2)

Publication Number Publication Date
ES2074965A1 true ES2074965A1 (es) 1995-09-16
ES2074965B1 ES2074965B1 (es) 1996-05-01

Family

ID=8285069

Family Applications (1)

Application Number Title Priority Date Filing Date
ES09400172A Expired - Fee Related ES2074965B1 (es) 1994-01-31 1994-01-31 Virus mutante recombinante de rinotraqueitis infecciosa bovina y vacunas que lo contienen.

Country Status (3)

Country Link
EP (1) EP0668356A3 (es)
CA (1) CA2141392A1 (es)
ES (1) ES2074965B1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5783195A (en) * 1991-07-18 1998-07-21 Syntro Corporation Recombinant infectious bovine rhinotracheitis virus S-IBR-052 and uses thereof
US6284251B1 (en) * 1996-02-26 2001-09-04 Kansas State University Research Foundation BHV-1 gene-deleted virus vaccine
CN101818130B (zh) * 2009-12-24 2012-07-25 华中农业大学 一种缺失gG和TK基因的重组牛传染性鼻气管炎病毒和应用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4569840A (en) * 1983-02-25 1986-02-11 Baylor College Of Medicine Thymidine kinase-negative temperature resistant bovine herpesvirus-1 mutant as a vaccine against infectious bovine rhinotracheitis
WO1987000862A1 (en) * 1985-07-29 1987-02-12 The Upjohn Company Virus vaccine
US4703011A (en) * 1985-11-12 1987-10-27 Novagene, Inc. Thymidine kinase deletion mutants of bovine herpesvirus-1

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2693472B1 (fr) * 1992-06-26 1994-12-23 Rhone Merieux Mutants du virus de la rhinotrachéite infectieuse bovine, délétés dans l'un des gènes des glycoprotéines mineures, vaccins préparés à partir de ces souches, méthodes de production et méthodes d'utilisation.
NL9100989A (nl) * 1991-06-07 1993-01-04 Stichting Centr Diergeneeskund Bovine herpesvirus type 1 deletiemutanten, daarop gebaseerde vaccins, diagnostische kits voor detectie van bovine herpesvirus type 1.
WO1993002104A1 (en) * 1991-07-18 1993-02-04 Syntro Corporation Recombinant infectious bovine rhinotracheitis virus
WO1994024296A2 (en) * 1993-04-19 1994-10-27 University Of Saskatchewan Recombinant bovine herpesvirus type 1 vaccines

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4569840A (en) * 1983-02-25 1986-02-11 Baylor College Of Medicine Thymidine kinase-negative temperature resistant bovine herpesvirus-1 mutant as a vaccine against infectious bovine rhinotracheitis
WO1987000862A1 (en) * 1985-07-29 1987-02-12 The Upjohn Company Virus vaccine
US4703011A (en) * 1985-11-12 1987-10-27 Novagene, Inc. Thymidine kinase deletion mutants of bovine herpesvirus-1

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ISABELLA RAUH et al. Pseudorabies virus mutants lacking the essential glycoprotein gII can be complemented by glycoprotein gI of bovine herpesvirus 1. Journal of Virology. Febrero 1991, pßginas 621-631 * Todo el documento * *

Also Published As

Publication number Publication date
CA2141392A1 (en) 1995-08-01
ES2074965B1 (es) 1996-05-01
EP0668356A3 (en) 1998-09-02
EP0668356A2 (en) 1995-08-23

Similar Documents

Publication Publication Date Title
AU585126B2 (en) Recombinant herpes simplex viruses, vaccines and methods
PH25776A (en) Pseudorabies virus mutants incapable of producing glycoprotein x
AU6489986A (en) Thymidine kinase deletion mutants of bovine herpersvirus-1, vaccines against infectious bovine rhinotracheitis containing same and methods for the production and use of same
HU9603155D0 (en) Papillomavirus vaccines
MX9700833A (es) Virus de herpes recombinante de pavo y usos del mismo.
CA2031164A1 (en) Recombinant herpesvirus of turkeys and live vector vaccines derived thereof
ES8505719A1 (es) Procedimiento de preparar mutantes de delecion vivos y metodo de preparar vacunas
GB9105383D0 (en) An immunotherapeutic for cervical cancer
AU2403188A (en) Infectious bovine rhinotracheitis virus mutants, vaccines containing same, methods for the production of same and methods for the use of same
WO1994000586A3 (fr) Mutants et vaccins du virus de la rhinotracheite infectieuse bovine
MXPA94008605A (es) Replicacion de un virus no patogenico que expresalas glicoproteinas de la envoltura del virus de ladiarrea viral bovina (bvdv).
ES2074965A1 (es) Virus mutante recombinante de rinotraqueitis infecciosa bovina y vacunas que lo contienen.
GB9818133D0 (en) Vaccine
NZ220645A (en) Modified varicella-zoster virus and its cultivation
NZ242641A (en) Herpesvirus particles lacking a capsid and viral dna and viral preparations containing them

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20040916